Please note that changes and additions to the agenda may occur. Stay informed by revisiting this page in the lead-up to the event.
08:30 Registration, Partnering Meetings & Networking in the Exhibition Hall
09:00 Welcome & Introduction
Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology
09:05 Enabling and Intensifying Manufacturing of Biologics
Véronique Chotteau, Professor in Mammalian Cell-Based Bioprocess Technology, KTH Royal Institute of Technology
09:30 In-House Development of a Protein-Based Biological Drug: A Next-Generation Botulinum Neuromodulator Product for the Aesthetic Market
Ulf Ståhl, Product Research Leader, Galderma
09:55 Coffee, Partnering Meetings & Networking in the Exhibition Hall
10:30 BRIDGE Sweden – Accelerating Biologics Development through National Collaboration
Alexandra Patriksson, Senior Manager, Testa Center
Klas Bratteby, Research Specialist, Karolinska Institutet
Niklas Berndt Thalén, Research Scientist, Drug Discovery and Development Platform, SciLifeLab Solna
10:55 To Be Announced
11:20 Karolinska ATMP Centre: Accelerating Translational Research into Clinical Application
Knut Steffensen, Director, Karolinska ATMP Center, Karolinska Institutet
11:45 Lunch, Partnering Meetings & Networking in the Exhibition Hall
12:45 Introducing Cell and Gene Therapies in Sweden – the Role of the New Therapies Council
Åsa Derolf, Chair of the New Therapies Council (NT-rådet)
13:10 The Price of Innovation: How Do We Ensure Access to Gene Therapy?
– New payment models are needed for life-changing rare disease therapies
Fredrik Sjöö, Head of Medical Affairs, Nordic Region, CSL Behring
13:35 Immune Checkpoint Induction by a Topical Oligonucleotide Therapy for Atopic Dermatitis
Anna-Lena Spetz, Chief Scientific Officer, TIRmed Pharma
14:00 Coffee, Partnering Meetings & Networking in the Exhibition Hall
14:30 CAR-T Cells – Swedish Experiences
Gunilla Enblad, Professor in Oncology, Uppsala University
14:55 Transplantation of Allogeneic Beta Cells with No Immunosuppression
Per-Ola Carlsson, Professor in Medical Cell Biology, Uppsala University
15:20 More info coming soon!
Olof Nord, CEO, ScandiBio Therapeutics
15:45 Summary & Conclusion
Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology
16:00 Flemingsberg Science Christmas Party
Food and drinks, music and entertainment, and more – included for everyone!
Read more and register here.
Denna webbplats använder cookies för att säkerställa att du får den bästa upplevelsen på vår webbplats. Du kan alltid hantera dina inställningar i rutan här.
Hantera dina cookie preferenser här:
Bidrar till att tjänsten är säker och fungerar som den ska och för att komma ihåg dina cookie-inställningar. De går därför inte att stänga av.
Statistikcookies samlar in information anonymt. Denna information hjälper oss att förstå hur våra besökare använder vår webbplats.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com
Hitta mer information i vår Cookie Policy.